Kathryn J. Collier - 16 Jun 2025 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Reporting relationship: Director
Issuer ticker: RGLS
Reported as of: 16 Jun 2025
Net transaction value: +$60,060
SEC form: 4
Accepted by SEC: 18 Jun 2025, 17:00:04 UTC
Prior SEC filing: 30 Apr 2025
Next SEC filing: 27 Jun 2025
Source filing: View source filing
Reporting owner signature: Christopher Aker, Attorney in Fact

Key filing fact

Kathryn J. Collier filed Form 4 for Regulus Therapeutics Inc. (RGLS) on 18 Jun 2025.

Key facts

This page summarizes Kathryn J. Collier's Form 4 filing for Regulus Therapeutics Inc. (RGLS).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 18 Jun 2025, 17:00.

Change

Previous filing in this sequence was filed on 30 Apr 2025.
Current net transaction value: +$60,060.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001737436 Primary reporting owner

Collier Kathryn J

Relationship: Director
Address: C/O REGULUS THERAPEUTICS, 4224 CAMPUS POINT COURT #210, SAN DIEGO
Signature: Christopher Aker, Attorney in Fact
Signature date: 18 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGLS transaction

Common Stock

Options Exercise

Transaction value: $13,820
Shares: +1,396
Change %: +2.1%
Price: $9.90
Shares after: 67,844
Date: 16 Jun 2025
Ownership: Direct

RGLS transaction

Common Stock

Options Exercise

Transaction value: $25,780
Shares: +2,604
Change %: +4.2%
Price: $9.90
Shares after: 65,240
Date: 17 Jun 2025
Ownership: Direct

RGLS transaction

Common Stock

Options Exercise

Transaction value: $20,460
Shares: +2,325
Change %: +3.8%
Price: $8.80
Shares after: 62,915
Date: 17 Jun 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RGLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,396
Change %: -35%
Price: $0.000000
Shares after: 2,604
Date: 16 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,396
Exercise price: $9.90

RGLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,604
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,604
Exercise price: $9.90

RGLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,325
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,325
Exercise price: $8.80

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .